Atle Fund Management AB
Atle Fund Management AB reported 39 stocks worth $372M in its 13F filing for Q2 2026, filed Jul 24, 2026. Its largest holdings are LLY (9.6%), MRK (6.5%) and JNJ (5.8%). Compared with Q1 2026, the fund opened new positions in BIIB, ORKA and JBIO, added to MRK, CVS and TMO, trimmed LLY, JNJ and ABBV and sold out of AMGN and UNH.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  LLY Eli Lilly & Co | $35.8M | 9.6% | 30K | −9,901 (−25%) | 8 of 8 | |
| 2 |  MRK Merck & Co Inc | $24.3M | 6.5% | 189K | +156K (+459%) | 8 of 8 | |
| 3 |  JNJ Johnson & Johnson | $21.7M | 5.8% | 85K | −6,952 (−8%) | 2 of 8 | |
| 4 |  ABBV Abbvie Inc | $16.2M | 4.3% | 64K | −44K (−41%) | 8 of 8 | |
| 5 |  CVS Cvs Health Corp | $15.1M | 4.1% | 146K | +122K (+515%) | 3 of 8 | |
| 6 |  TMO Thermo Fisher Scientific Inc | $14M | 3.8% | 28K | +4,873 (+21%) | 8 of 8 | |
| 7 |  RVMD Revolution Medicines Inc | $13.7M | 3.7% | 73K | −544K (−88%) | 7 of 8 | |
| 8 |  BIIB Biogen Inc | $13.6M | 3.6% | 63K | New position | 1 of 8 | |
| 9 |  NBIX Neurocrine Biosciences Inc | $12.3M | 3.3% | 73K | −17K (−19%) | 8 of 8 | |
| 10 |  MIRM Mirum Pharmaceuticals Inc | $11.8M | 3.2% | 101K | −95K (−49%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Jul 24, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Atle Fund Management AB 13F FAQ
What does Atle Fund Management AB own?
Atle Fund Management AB reported 39 stocks worth $372M in its 13F filing for Q2 2026, filed Jul 24, 2026. Its largest holdings are LLY (9.6%), MRK (6.5%) and JNJ (5.8%). The table above lists every position in the filing (the top 10 without an account).
What did Atle Fund Management AB buy and sell in Q2 2026?
Compared with Q1 2026: 3 new positions, 16 added to, 20 trimmed and 3 sold out. New positions include BIIB, ORKA and JBIO. It sold all of AMGN and UNH.
When will Atle Fund Management AB file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Atle Fund Management AB's portfolio worth?
The Q2 2026 filing reports $372M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.